Filter
761
Text search:
tb
action
plan
Featured
Recommendations
63
New Publications
212
Language
Document type
No document type
487
Studies & Reports
109
Guidelines
67
Strategic & Response Plan
45
Manuals
23
Fact sheets
11
Training Material
9
Situation Updates
6
Resource Platforms
2
Infographics
2
Countries / Regions
India
43
South Africa
31
Kenya
30
Malawi
25
Global
24
Western and Central Europe
22
Ethiopia
17
Ghana
17
Zambia
17
Nigeria
14
Tanzania
14
Eastern Europe
14
Uganda
13
Rwanda
13
Bangladesh
13
Africa
13
Sierra Leone
12
Namibia
11
Lesotho
11
Liberia
10
Nepal
10
Myanmar / Burma
9
Philippines
8
Zimbabwe
7
Senegal
6
South–East Asia Region
6
Latin America and the Carribbean
6
Congo, Democratic Republic of
4
Indonesia
4
Ukraine
4
Botswana
4
Asia
4
South Sudan
3
Cambodia
3
Mozambique
3
Benin
3
Madagascar
3
Burkina Faso
2
Cameroon
2
Haiti
2
Pakistan
2
Papua New Guinea
2
Sudan
2
Peru
2
Western Pacific Region
2
Venezuela
2
Armenia
2
Tajikistan
2
Moldova
2
Morocco
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Syria
1
Singapore
1
Central African Republic
1
Argentina
1
Eswatini/ Swaziland
1
Burundi
1
Colombia
1
Sri Lanka
1
East and Southern Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Bhutan
1
Albania
1
Southern Africa
1
Timor Leste/ East Timor
1
Russia
1
Iran
1
Georgia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
348
Clinical Guidelines
41
Key Resources
28
Public Health
26
Women & Child Health
22
Capacity Building
7
Pharmacy & Technologies
4
Annual Report MEDBOX
1
Toolboxes
TB
132
HIV
96
AMR
47
COVID-19
31
Caregiver
14
Health Financing Toolbox
12
Mental Health
11
Pharmacy
11
Disability
10
NCDs
10
Polio
9
Global Health Education
9
NTDs
9
Natural Hazards
8
Conflict
7
Refugee
7
Planetary Health
7
Ebola & Marburg
4
Rapid Response
4
Specific Hazards
2
2.0 Rapid Response
2
Cholera
1
Zika
1
Social Ethics
1
Meeting report, 25-26 September 2017 Copenhagen, Denmark
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
The Government of Malawi is committed to improving health and livelihoods in Malawi through community health – the
provision of basic health services in rural and urban communities with the participation of people who live there.
Historically, Community Health has significantly contributed to im
...
Policy statement.
Myanmar continues to present a complex and dynamic operating context where ongoing socio-economic and political challenges, including conflict, displacement, widespread poverty and food insecurity, hinder development efforts. An estimated 24.8 percent of its 54 million population live near or below
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution
...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn
...
Primary Care: The Community Health System
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
For 100 cases among which 60 cases of children ≥ 5 years old and 40 cases of children < 5 years old and adults.
The new Pneumonia kit 2020 is specially designed to provide sufficient child-size antibiotics to treat pneumonia, targeting children under 5 years of age. It aims to provide life-saving treatment based o
...
